Data as of 12:44pm ET
| +0.40 / +1.55%|
The 5 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 40.00, with a high estimate of 43.00 and a low estimate of 37.00. The median estimate represents a +52.32% increase from the last price of 26.26.
The current consensus among 5 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.